Massive Creatine Kinase Elevation in 2 Patients During Short-Term and Low-Dose Antipsychotic Monotherapy With Quetiapine

J Clin Psychopharmacol. 2018 Aug;38(4):385-387. doi: 10.1097/JCP.0000000000000902.

Authors

Patrick Bach¹, Anne Koopmann, Derik Hermann, Falk Kiefer, Jan Malte Bumb

Affiliation

¹ Department of Addictive Behaviorand Addiction MedicineCentral Institute of Mental HealthUniversity of HeidelbergMedical Faculty Mannheim, Germanypatrick.bach@zi-mannheim.de Department of Addictive Behavior and Addiction Medicine Central Institute of Mental Health University of Heidelberg Medical Faculty Mannheim, Germany.

PMID: 29901562
DOI: 10.1097/JCP.0000000000000902

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antipsychotic Agents / adverse effects*
Antipsychotic Agents / therapeutic use
Creatine Kinase / blood*
Female
Humans
Male
Quetiapine Fumarate / adverse effects*
Quetiapine Fumarate / therapeutic use
Young Adult

Substances

Antipsychotic Agents
Quetiapine Fumarate
Creatine Kinase